Peer Review History: Predictors of Treatment Failure with Sofosbuvir/Daclatasvir Regimen for 12 Weeks in Patients with Chronic HCV in Egypt

Editor(s):

(1) Dr. Charbell Miguel Haddad Kury, Professor, University of Rio de Janeiro, Brazil.

Reviewers:

(1) Chieng Jin Yu, Pantai Hospital, Malaysia.

(2) Kasamba Ilunga Eric, Université de Lubumbashi, D R Congo.

(3) Bridget Okiemute Amechi, Federal Medical Centre, Nigeria.

Additional Reviewers:

(1) Hanan Mahmoud Fayed, South Valley University, Egypt.

(2) Ishtiaq Ahmed, ISRA University, Pakistan.

(3) Chinmaya Keshari Sahoo, College of Pharmaceutical Sciences, India.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 9.03/10

Average Peer review marks at publication stage: 9.50/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Chieng Jin Yu, Malaysia) | File 1 | NA


Stage 2 | Peer review report_2 (Kasamba Ilunga Eric, D R Congo) | File 1 | NA


Stage 2 | Peer review report_3 (Bridget Okiemute Amechi, Nigeria) | File 1 | NA


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA